2026 NPPES data Hematology & Oncology Physician NPI 1588622674 MD
Verify on CMS →

ROBERTO VELAZQUEZ TORRES, MD

Hematology & Oncology Physician in PONCE, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
933
Medicare Part D claims · 174 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$273.37
13 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERTO VELAZQUEZ TORRES, MD is a Hematology & Oncology Physician ([object Object]) practicing in PONCE, Puerto Rico with a Medicare Part D prescribing footprint of 933 claims across 174 beneficiaries — 24% brand-name prescribing . Industry payments of $273.37 across 13 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROBERTO VELAZQUEZ TORRES, MD filed 933 Medicare Part D claims in 2023 across PONCE, Puerto Rico. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

ROBERTO VELAZQUEZ TORRES, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

ROBERTO VELAZQUEZ TORRES, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/01/2006

NPI 1588622674

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

933 10% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Puerto Rico

How Hematology & Oncology Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers

Hematology & Oncology Physician share within Puerto Rico

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Puerto Rico

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERTO VELAZQUEZ TORRES, MD is a Hematology & Oncology Physician provider practicing in PONCE, Puerto Rico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1588622674. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERTO VELAZQUEZ TORRES, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at EDIFICIO PORRATA PILA 2431 AVE LAS AMERICAS, PONCE, PR, 00717, with a listed phone of (787) 841-0587. NPI 1588622674 was issued on 05/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VELAZQUEZ TORRES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 933 prescription claims written by this provider, covering 174 Medicare beneficiaries and totaling roughly $3.0 million in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 6.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

EDIFICIO PORRATA PILA 2431 AVE LAS AMERICAS
PONCE, PR 00717

Provider Details

NPI 1588622674
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 05/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERTO VELAZQUEZ TORRES, MD. Source: openpaymentsdata.cms.gov.

Total received

$273

Largest payer

PBG PUERTO RICO LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ROBERTO VELAZQUEZ TORRES, MD — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 933 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

933
Total Claims
$3.0M
Total Drug Cost
174
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,045
Total Day Supply
28,684
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$2.8M
Generic Drug Cost
$133K
Opioid Claims
61 (6.5% rate)
Antibiotic Claims
11

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
2.43
Gender Split
55% female / 45% male
Age Distribution
<65: 16, 65-74: 77, 75-84: 62, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
146
Imbruvica
Ibrutinib
73
Hydroxyurea
72
Imatinib Mesylate
70
Exemestane
40
Prednisone
35
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
34
Dexamethasone
27
Revlimid
Lenalidomide
27
Ondansetron Hcl
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How ROBERTO VELAZQUEZ TORRES, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

ROBERTO VELAZQUEZ TORRES, MD's 933 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as VELAZQUEZ TORRES.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERTO VELAZQUEZ TORRES, MD's specialty?
ROBERTO VELAZQUEZ TORRES, MD specializes in Hematology & Oncology Physician and practices in PONCE, Puerto Rico. Credentials: MD.
How much does ROBERTO VELAZQUEZ TORRES, MD prescribe under Medicare Part D?
In 2023, ROBERTO VELAZQUEZ TORRES, MD wrote 933 Medicare Part D claims totaling $3.0M in drug costs for 174 beneficiaries.
Where is ROBERTO VELAZQUEZ TORRES, MD located?
ROBERTO VELAZQUEZ TORRES, MD is located at EDIFICIO PORRATA PILA 2431 AVE LAS AMERICAS, PONCE, PR, 00717. Phone: (787) 841-0587.
What is ROBERTO VELAZQUEZ TORRES, MD's NPI number?
ROBERTO VELAZQUEZ TORRES, MD's National Provider Identifier (NPI) is 1588622674, issued on 05/01/2006.
Does ROBERTO VELAZQUEZ TORRES, MD prescribe more brand-name or generic drugs?
ROBERTO VELAZQUEZ TORRES, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $2.8M in brand drug costs.
Does ROBERTO VELAZQUEZ TORRES, MD prescribe opioids?
Yes, ROBERTO VELAZQUEZ TORRES, MD had 61 opioid claims in 2023 with an opioid prescribing rate of 6.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does ROBERTO VELAZQUEZ TORRES, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERTO VELAZQUEZ TORRES, MD's most frequently prescribed drugs include Anastrozole, Imbruvica, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERTO VELAZQUEZ TORRES, MD accept Medicare?
ROBERTO VELAZQUEZ TORRES, MD appears in CMS Medicare data with 933 Part D claims and 174 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERTO VELAZQUEZ TORRES, MD's credentials?
ROBERTO VELAZQUEZ TORRES, MD's NPI is 1588622674 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology